MMRV vaccine
Selected indexed studies
- MMRV vaccine safety. (Vaccine, 2019) [PMID:29526373]
- MMRV vaccine safety: A comprehensive analysis of adverse events recorded among pediatric populations. (Hum Vaccin Immunother, 2025) [PMID:41410649]
- Infantile Sweet syndrome following MMRV vaccine. (Pediatr Dermatol, 2023) [PMID:36373208]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Phase 3 Safety and Immunogenicity Study of a Three-dose Series of Twenty-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers. (2024) pubmed
- MMRV vaccine safety. (2019) pubmed
- MMRV vaccine safety: A comprehensive analysis of adverse events recorded among pediatric populations. (2025) pubmed
- Infantile Sweet syndrome following MMRV vaccine. (2023) pubmed
- Immunogenicity and reactogenicity of tetravalent vaccine for measles, mumps, rubella and varicella (MMRV) in healthy children: a meta-analysis of randomized controlled trials. (2015) pubmed
- Second dose of measles-mumps-rubella-varicella vaccine (MMRV) and the risk of febrile convulsions. (2022) pubmed
- Measles-Mumps-Rubella-Varicella Vaccine. (2006) pubmed
- Effectiveness of the combined MMRV Priorix-Tetra™ vaccine against varicella in a large Italian region: A case-control study. (2024) pubmed
- Adverse Events After MMR or MMRV Vaccine in Infants Under Nine Months Old. (2016) pubmed
- A systematic review and meta-analysis of adverse events following measles-containing vaccines in infants less than 12 months of age. (2025) pubmed